The researcher at the University of Greifswald (Germany) who identified the cause of , Andreas Greinacher, assures that young women are not at greater risk of suffering from these adverse effects.
AstraZeneca thrombosis is not a disease of young women
The majority of thromboembolic events in AstraZeneca vaccinees have been reported in young women. Thus, some European countries, such as Spain, made the decision to only administer the Oxford saline in people over 60 years of age to maximize the benefits compared to the risk. In the same way, the Ministry of Health made the decision to administer the Janssen vaccine, which also produces thrombi, only in people over 70 years of age.
These decisions, however, have not followed scientific criteria, since the European Medicines Agency (EMA) found no risk factors in cases of thrombosis. In the same way, the scientist Andreas Greinacher, asked about, explains that he is “increasingly skeptical” about the correlation between cases of thrombosis with sex and age.
“In Germany it occurs in young women because 73% of the toilets are,” explained the scientist. “The information I have from Canada is that they are beginning to see it in men and women alike, and in the United Kingdom it is quite balanced, although it tends somewhat towards women. It is not a disease of young women,” he said. However, the expert commented that women are somewhat more likely to develop an autoimmune response, which is the trigger for clotting.
Facebook Comments
Disqus